Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.25 USD | -0.53% | -7.34% | +29.88% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
Financials (USD)
Sales 2024 * | 2.19M | Sales 2025 * | 2.67M | Capitalization | 6.15B |
---|---|---|---|---|---|
Net income 2024 * | -510M | Net income 2025 * | -581M | EV / Sales 2024 * | 2,183 x |
Net cash position 2024 * | 1.37B | Net cash position 2025 * | 846M | EV / Sales 2025 * | 1,987 x |
P/E ratio 2024 * |
-11.9
x | P/E ratio 2025 * |
-10.5
x | Employees | 411 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.97% |
Latest transcript on Revolution Medicines, Inc.
1 day | -0.53% | ||
1 week | -7.34% | ||
Current month | -0.08% | ||
1 month | -0.43% | ||
3 months | +22.37% | ||
6 months | +88.99% | ||
Current year | +29.88% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 14-09-30 |
Jack Anders
DFI | Director of Finance/CFO | 47 | 18-07-31 |
Wally Reiher
CTO | Chief Tech/Sci/R&D Officer | - | 15-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 14-09-30 |
Alexis Borisy
BRD | Director/Board Member | 52 | 14-10-31 |
Sandra Horning
BRD | Director/Board Member | 75 | Nov. 08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 0 M€ | 0.00% | - | |
0.12% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 37.25 | -0.53% | 1,013,329 |
24-05-09 | 37.45 | -2.24% | 1,234,702 |
24-05-08 | 38.31 | -1.47% | 916,440 |
24-05-07 | 38.88 | -0.44% | 925,062 |
24-05-06 | 39.05 | -2.86% | 1,388,307 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.88% | 6.15B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- RVMD Stock